While Mainz Biomed N.V has underperformed by -2.82%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MYNZ fell by -89.31%, with highs and lows ranging from $49.60 to $3.65, whereas the simple moving average fell by -75.14% in the last 200 days.
On November 25, 2024, H.C. Wainwright Downgraded Mainz Biomed N.V (NASDAQ: MYNZ) to Neutral. A report published by Cantor Fitzgerald on November 21, 2023, Downgraded its rating to ‘Neutral’ for MYNZ. H.C. Wainwright also rated MYNZ shares as ‘Buy’, setting a target price of $25 on the company’s shares in an initiating report dated June 21, 2022.
Analysis of Mainz Biomed N.V (MYNZ)
One of the most important indicators of Mainz Biomed N.V’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 0.91, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and MYNZ is recording 119.68K average volume. On a monthly basis, the volatility of the stock is set at 20.75%, whereas on a weekly basis, it is put at 24.37%, with a gain of 16.06% over the past seven days. Furthermore, long-term investors anticipate a median target price of $160.00, showing growth from the present price of $4.82, which can serve as yet another indication of whether MYNZ is worth investing in or should be passed over.
How Do You Analyze Mainz Biomed N.V Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.91%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 0.24% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
MYNZ shares are owned by institutional investors to the tune of 0.24% at present.
